Elsevier

International Journal of Cardiology

Volume 227, 15 January 2017, Pages 413-423
International Journal of Cardiology

Review
The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure — A meta-analysis

https://doi.org/10.1016/j.ijcard.2016.11.023Get rights and content

Highlights

  • Resistance training (RT) as a single intervention can increase muscle strength, VO2peak, and quality of life in patients with CHF.

  • The effect of RT on muscle strength is mainly during slow, but not rapid movements.

  • Older patients and patients with advanced CHF are underrepresented in resistance training controlled trials.

Abstract

Background

Resistance training (RT) has been utilised to target muscle dysfunction associated with Chronic Heart Failure (CHF). However, there is limited meta-analysis evidence to support its use as a standalone therapy. This meta-analysis examined the effects of RT on muscle strength (one repetition maximum, 1RM and Peak Torque), aerobic capacity (VO2peak and 6 min walk distance) and quality of life (QoL) in patients with CHF.

Methods

We searched Medline, EMBASE, Cochrane and CINAHL for studies published up to July 2016, combining terms related to the population (eg, heart failure, CHF) with terms for the intervention (eg, resistance, strength training) and the outcomes (eg, QoL, VO2 peak, strength, aerobic capacity).

Results

Ten studies including 240 participants were included in our meta-analysis (aged 48–76 years, Ejection Fraction 18–37%). Training duration ranged from 8 to 24 weeks and intensity up to 80% of 1RM. RT increased 1RM (standardised change score = 0.60; 95% Confidence Interval: 0.43, 0.77) but not strength measured via peak torque at 60°/s1 and 180°/s1. RT increased VO2peak (CSMD: 2.71 ml/kg/min; 1.96, 3.45) and QoL (CSMD: − 5.71; − 9.85, − 1.56).

Conclusion

RT as a single intervention can increase muscle strength, aerobic capacity and QoL in patients with CHF and may offer an alternative approach, particularly for those unable to participate in aerobic training. The effect of RT on muscle strength is mainly during slow controlled movements and not during rapid movements. Older adults and patients with advanced CHF are underrepresented in RT trials and future studies should seek to optimise their inclusion.

Introduction

Chronic Heart Failure (CHF) is a dynamic and progressive syndrome, which develops secondary to structural or functional abnormalities of cardiac tissue. It leads to the inability of the heart to supply enough blood to meet the body's metabolic needs and causes breathlessness, fatigue and reduced exercise tolerance [1]. Life expectancy in patients with CHF is increasing however, many of these recovered years are spent with debilitating burden of symptoms [2], high incidence of hospitalisations [3], [4] and a poor ultimate prognosis [4].

Treatment for patients with CHF is alike other terminal illnesses and is primarily focussed on managing symptoms and maintaining quality of life (QoL). Exercise training is an integral component of this paradigm [5], [6], [7] due to its capacity to ameliorate symptoms [8], reduce hospital admissions [9] and improve functional capacity, which translate into improved QoL [8], [10], [11], [12]. Traditional approaches to exercise rehabilitation have largely focussed on aerobic-based training given its ability to increase aerobic capacity (VO2peak) [13], [14], [15]. However, it is now accepted that exercise intolerance in CHF is not exclusively due to central cardiovascular factors and consequently, clinicians are moving beyond a centrally focussed treatment approach. Specifically, the “muscle hypothesis” argues that abnormalities in peripheral muscle tissue initiate deleterious feedback loops and become drivers for disease progression [16]. Adding to the fact that muscle mass is strongly correlated with VO2peak [17], [18] it has been argued that targeting muscle dysfunction may interrupt these maladaptive feedback loops and improve exercise tolerance [19].

Resistance training (RT) is normally employed for conditioning skeletal muscle tissue however, it was largely overlooked for patients with CHF prior to 1990’s due to concerns that high cardiac afterload may adversely affect left ventricular remodelling [8], [20]. More recently, modern methods of hemodynamic measurement have allayed these concerns by confirming the integrity of the left ventricle during RT [12], [21]. With confirmation of safety and acknowledgment of the wider health and fitness benefits, RT is now supported in clinical practice guidelines for people with cardiovascular disease [22]. There are however, several unresolved limitations to these guidelines, which continue to impact on clinical decision making.

Firstly is the question of applicability of current best practice guidelines to patients with CHF. The joint council Scientific Statement from the American Heart Association recommends RT for individuals with and without cardiovascular disease [22]. The guideline presents a consensus of evidence supporting the safety and efficacy of RT through large randomised controlled trials and meta-analyses. However, these data are largely derived from patients with cardiovascular diseases other than CHF, or in patients with few comorbidities or risk factors. In specific reference to CHF, the guidelines are based on only a small number of individual studies [23], [24]. The precision of estimates of effects derived from such studies is limited and authors acknowledged the need for further evidence. The consequences of overly generalised guidelines for cardiovascular disease is particularly problematic in CHF, since it is the end stage of other cardiovascular conditions and as such, patients often suffer from multi-organ and co-morbid disease which can further challenge management. For instance, Havranek et al. [25]. reported an incidence of diabetes and chronic obstructive pulmonary disease of 40% and 33%, respectively, in elderly patients with CHF.

Secondly, patients with CHF are generally older than those with other cardiovascular conditions, yet this age discrepancy is largely unaddressed in these guidelines. The Framingham Heart study reported a mean age of diagnosis of 76.4 years for CHF [26], compared to 56 or 65 years for the median age of first myocardial infarction, for men and women respectively [27]. Patients with CHF, particularly those who are elderly, are a heterogeneous group and differ significantly from patients with other cardiovascular diseases. The complexity of the illness merits exclusive exercise recommendations for treatment. It is for this reason, that explicit medical guidelines exist for patients with CHF which pay specific attention to the management of co-morbidities, as well as issues related to older age [28].

Finally, the focus for cardiac rehabilitation remains heavily on aerobic or centrally focussed training and limited evidence exists to support RT as an effective standalone therapy. It was previously reported that RT has a smaller effect compared to aerobic training in increasing peak VO2 in patients with CHF [29], however RT produces greater improvements in skeletal muscle strength and endurance [30]. The American Heart Association acknowledges the potential benefits of RT for cardiovascular health, weight management and prevention of disability and falls, however, given the extensive benefits of aerobic training, RT was not recommended to be used as its substitute [22]. Some clinicians and researchers have argued that many patients have insufficient capacity to tolerate aerobic exercise, such as those who are elderly or have more advanced CHF and that RT may be a suitable alternative for these patients [31], [32], [33].

Systematic reviews and meta-analysis are the reference standard for developing clinical practice guidelines because of their methodological rigour and assessment of potential bias. To our knowledge only one meta-analysis has analysed the effects of RT versus usual care in patients with CHF [34], however this study did not analyse muscular strength. Therefore, the purpose of this meta-analysis was to systematically review randomised controlled trials (including quasi-randomised designs) and meta-analyse the effects of RT, as a single intervention, on muscle strength, aerobic capacity and QoL in patients with CHF.

Section snippets

Search strategy

With the support from a clinical librarian, we developed search strategies to identify controlled trials of RT in patients with CHF. Specifically, we focussed on the effect of RT on muscle strength (1 repetition maximum, 1RM, and/or peak isokinetic torque), aerobic capacity (measured by VO2 peak and/or 6 min walk distance [6MWD]), and QoL measured using the Minnesota Living with Heart Failure questionnaire. We searched CINAHL, Medline, EMBASE, and Cochrane databases up to 10th July, 2016. In

Study selection

The search strategy identified 10,424 citations. After removal of duplicates, 7650 were broadly screened by title and abstract and 7596 articles were excluded. Fifty-five articles were included for full text review. Of these, a further 45 were excluded leaving 10 articles for inclusion in the meta-analysis. The reasons for excluding articles are shown in Fig. 2; 19 papers did not report on the outcome(s) of interest. One additional study was identified incidentally while confirming inclusion

Discussion

The main findings of the current meta-analysis are that RT as a single intervention can increase muscle strength, aerobic capacity, and QoL in patients with CHF. However the effect of RT on muscle strength is mainly during slow controlled movements (1RM) and not during rapid movements. Older adults, who are the vast majority of patients with CHF, are underrepresented across studies and there are no RT studies in patients with severe CHF (NYHA IV).

To our knowledge, only one previous

Conflict of interest

The authors report no relationships that could be construed as a conflict of interest.

Acknowledgements

Associate Professor Levinger is supported by Future Leader Fellowship (ID: 100040) from the National Heart Foundation of Australia. We would like to thank Evelyn Hutcheon and Steven Chang from Western Health library service for their help with the literature search.

References (70)

  • R. Trowman

    The impact of trial baseline imbalances should be considered in systematic reviews: a methodological case study

    J. Clin. Epidemiol.

    (2007)
  • I. Levinger

    Resistance training for chronic heart failure patients on beta blocker medications

    Int. J. Cardiol.

    (2005)
  • S.E. Selig

    Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow

    J. Card. Fail.

    (2004)
  • A. Beniaminovitz

    Selective low-level leg muscle training alleviates dyspnea in patients with heart failure

    J. Am. Coll. Cardiol.

    (2002)
  • U. Corrà

    Cardiopulmonary exercise testing and prognosis in chronic heart failure*: a prognosticating algorithm for the individual patient

    Chest

    (2004)
  • S.D. Anker

    Wasting as independent risk factor for mortality in chronic heart failure

    Lancet

    (1997)
  • L. Han et al.

    Strength or power, which is more important to prevent slip-related falls?

    Hum. Mov. Sci.

    (2015)
  • J.A. Sterne et al.

    Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

    J. Clin. Epidemiol.

    (2000)
  • P. Ponikowski

    2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure

    Eur. Heart J.

    (2016)
  • C.H. Zambroski

    Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure

    Eur. J. Cardiovasc. Nurs.

    (2005)
  • P.S. Jhund

    Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people

    Circulation

    (2009)
  • H. Krum

    2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006

    Med. J. Aust.

    (2011)
  • G.W. Moe

    The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization

    Can. J. Cardiol.

    (2013)
  • I.L. Piña

    Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention

    Circulation

    (2003)
  • C.M. O'Connor

    Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

    JAMA

    (2009)
  • P.M. Davidson

    Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients?

    Eur. J. Cardiovasc. Prev. Rehabil.

    (2010)
  • M. Haykowsky

    Supervised exercise training improves aerobic capacity and muscle strength in older women with heart failure

    Can. J. Cardiol.

    (2005)
  • B.A. Tol

    Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: a meta-analysis (structured abstract)

    Eur. J. Heart Fail.

    (2006)
  • C.M. O'Connor

    Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

    JAMA

    (2009)
  • M.F. Piepoli et al.

    The ‘skeletal muscle hypothesis in heart failure’ revised

    Eur. Heart J.

    (2013)
  • J.P. LeMaitre

    Maximum oxygen uptake corrected for skeletal muscle mass accurately predicts functional improvements following exercise training in chronic heart failure

    Eur. J. Heart Fail.

    (2006)
  • M. Piepoli

    Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training

    Circulation

    (1996)
  • J.H. Mitchell et al.

    Static (isometric) exercise and the heart: physiological and clinical considerations

    Annu. Rev. Med.

    (1974)
  • A.E. Karlsdottir

    Hemodynamic responses during aerobic and resistance exercise

    J. Cardpulm. Rehabil.

    (2002)
  • M.A. Williams

    Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on clinical cardiology and council on nutrition, physical activity, and metabolism

    Circulation

    (2007)
  • Cited by (87)

    • Exercise for chronic heart failure

      2022, Exercise to Prevent and Manage Chronic Disease Across the Lifespan
    View all citing articles on Scopus
    View full text